Biogen
announces a 50% price cut for its Alzheimer's drug - Advisory Board
Advisory Board
In comparison, Medicare Part B's most significant cost
expenditure in ... said they had to plan for a "high-cost
scenario of Aduhelm coverage.
|
|
|
Wednesday, December 29, 2021
Biogen announces a 50% price cut for its Alzheimer's drug - Advisory Board
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment